Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Eton Pharmaceuticals (ETON) Debt to Equity: 2020-2024

Historic Debt to Equity for Eton Pharmaceuticals (ETON) over the last 5 years, with Dec 2024 value amounting to $1.22.

  • Eton Pharmaceuticals' Debt to Equity rose 408.72% to $1.31 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.00, marking a year-over-year increase of 149.74%. This contributed to the annual value of $1.22 for FY2024, which is 251.07% up from last year.
  • Latest data reveals that Eton Pharmaceuticals reported Debt to Equity of $1.22 as of FY2024, which was up 251.07% from $0.35 recorded in FY2023.
  • In the past 5 years, Eton Pharmaceuticals' Debt to Equity ranged from a high of $1.22 in FY2024 and a low of $0.02 during FY2020.
  • Its 3-year average for Debt to Equity is $0.55, with a median of $0.35 in 2023.
  • Per our database at Business Quant, Eton Pharmaceuticals' Debt to Equity soared by 349.93% in 2021 and then dropped by 1.79% in 2022.
  • Over the past 5 years, Eton Pharmaceuticals' Debt to Equity (Yearly) stood at $0.02 in 2020, then surged by 349.93% to $0.08 in 2021, then dropped by 1.79% to $0.08 in 2022, then spiked by 340.08% to $0.35 in 2023, then surged by 251.07% to $1.22 in 2024.